Stahr K, Hubl W, Scheuch D W
Institute of Pathological Biochemistry, Medical Academy Carl Gustav Carus, Dresden, GDR.
Exp Clin Endocrinol. 1988 Sep;92(1):106-10. doi: 10.1055/s-0029-1210788.
A competitive bradykinin enzymeimmunoassay (BK-EIA) for the determination of urinary kinins was developed. The BK-EIA was based on a stable BK-peroxidase conjugate and a BK-antirabbit-antiserum. Compared with a healthy control group, a significantly lower mean kinin excretion was found in patients with essential hypertension.
开发了一种用于测定尿激肽的竞争性缓激肽酶免疫测定法(BK-EIA)。该BK-EIA基于稳定的BK-过氧化物酶偶联物和BK-抗兔抗血清。与健康对照组相比,原发性高血压患者的平均激肽排泄量显著降低。